{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:02:14Z","timestamp":1791428534565,"version":"4.3.3"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006392","name":"Centre Hospitalier Universitaire Vaudois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.inpsyc.2026.100249","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T11:23:50Z","timestamp":1786188230000},"page":"100249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatments for vascular depression in older adults: A systematic review"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8973-9594","authenticated-orcid":false,"given":"Bernardo","family":"Fl\u00f4r-Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiene","family":"Ben Aissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3041-8287","authenticated-orcid":false,"given":"David","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Compagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7852-3803","authenticated-orcid":false,"given":"Armin","family":"von Gunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-5061","authenticated-orcid":false,"given":"Vasiliki","family":"Orgeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-1686","authenticated-orcid":false,"given":"Christoph","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Swierkosz-Lenart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Pozuelo Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.inpsyc.2026.100249_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12916-016-0720-5","article-title":"Vascular depression consensus report - a critical update","author":"Aizenstein","year":"2016","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpsychires.2012.01.011","article-title":"Vascular depression prevalence and epidemiology in the United States","volume":"46","author":"Gonz\u00e1lez","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.inpsyc.2026.100249_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2015.04.008","article-title":"Epidemiology of MRI-defined vascular depression: a longitudinal, community-based study in Korean elders","volume":"180","author":"Park","year":"2015","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/j.inpsyc.2026.100249_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpsyc.1997.01830220033006","article-title":"Vascular depression' hypothesis","volume":"54","author":"Alexopoulos","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib5","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","article-title":"Washington, DC","author":"American Psychiatric Association","year":"2013"},{"issue":"9","key":"10.1016\/j.inpsyc.2026.100249_bib6","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatry"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100249_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1176\/appi.ajp.2018.18050568","article-title":"Perspectives on the management of vascular depression","volume":"175","author":"Taylor","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100249_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/JGP.0b013e31822ccd64","article-title":"Vascular burden and cognitive functioning in depressed older adults","volume":"20","author":"Schneider","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jad.2025.03.169","article-title":"Treatment-resistant late-life depression prevalence and clinical\/sociodemographic correlates: an electronic health records study","volume":"381","author":"Pozuelo Moyano","year":"2025","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1590\/S1516-44462011000400015","article-title":"Therapeutic interventions for vascular depression: a systematic review","volume":"33","author":"Brunoni","year":"2011","journal-title":"Braz J Psychiatry"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100249_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1017\/S0033291709991656","article-title":"Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression","volume":"40","author":"Dalby","year":"2010","journal-title":"Psychol Med"},{"issue":"15","key":"10.1016\/j.inpsyc.2026.100249_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jpsychires.2010.03.006","article-title":"Response and remission criteria in major depression--a validation of current practice","volume":"44","author":"Riedel","year":"2010","journal-title":"J Psychiatr Res"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mpr.323","article-title":"Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder","volume":"19","author":"Matza","year":"2010","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.inpsyc.2026.100249_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2019.04.024","article-title":"A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China","volume":"114","author":"Chen","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.inpsyc.2026.100249_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpsychires.2022.12.023","article-title":"Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: A prospective randomized clinical trial","volume":"159","author":"Chen","year":"2023","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100249_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14650","article-title":"Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open-labeled randomized control trial","volume":"30","author":"Chen","year":"2024","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100249_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40263-025-01190-8","article-title":"Efficacy and Safety of Escitalopram Combined with Tandospirone Citrate in Treating Patients with Vascular Depression and Chronic Insomnia: A Randomized Controlled Trial","volume":"39","author":"Chen","year":"2025","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100249_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/gps.340","article-title":"A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression","volume":"16","author":"Taragano","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100249_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1017\/S1041610205001493","article-title":"A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of \"vascular depression\"","volume":"17","author":"Taragano","year":"2005","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100249_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archgenpsychiatry.2007.45","article-title":"Treatment of vascular depression using repetitive transcranial magnetic stimulation","volume":"65","author":"Jorge","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100249_bib21","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.brs.2020.08.013","article-title":"Transcranial direct current stimulation: a novel approach in the treatment of vascular depression","volume":"13","author":"Zanardi","year":"2020","journal-title":"Brain Stimul"},{"key":"10.1016\/j.inpsyc.2026.100249_bib22","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib23","article-title":"Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke","volume":"1","author":"Allida","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100249_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s100720200000","article-title":"Post-stroke and vascular depression: a critical review","volume":"22","author":"Provinciali","year":"2002","journal-title":"Neurol Sci"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100249_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMcp2305428","article-title":"Treatment-resistant depression in older adults","volume":"390","author":"Steffens","year":"2024","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0706743715620411","article-title":"Combining antidepressants in acute treatment of depression: a meta-analysis of 38 studies including 4511 patients","volume":"61","author":"Henssler","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopsych.2012.11.012","article-title":"Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder","volume":"74","author":"Gray","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib28","series-title":"Stahl Psychopharmacology Essentials: Basic and Clinical Applications in Neuroscience","author":"Stahl","year":"2011"},{"issue":"60","key":"10.1016\/j.inpsyc.2026.100249_bib29","doi-asserted-by":"crossref","first-page":"102705","DOI":"10.18632\/oncotarget.22170","article-title":"Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(01)00079-1","article-title":"Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex","volume":"40","author":"Yoshino","year":"2002","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100249_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjp.0703139","article-title":"Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex","volume":"129","author":"Sakaue","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100249_bib32","first-page":"62","article-title":"Prefrontal dopamine and behavioral flexibility: shifting from an \"inverted-U\" toward a family of functions","author":"Floresco","year":"2013","journal-title":"Front Neurosci"},{"issue":"9","key":"10.1016\/j.inpsyc.2026.100249_bib33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.biopsych.2022.02.015","article-title":"Depression and prefrontal cortex: all roads lead to dopamine","volume":"91","author":"Moghaddam","year":"2022","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100249_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063331","article-title":"Nimodipine Exerts Time-Dependent Neuroprotective Effect after Excitotoxical Damage in Organotypic Slice Cultures","volume":"23","author":"Hohmann","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"16-18","key":"10.1016\/j.inpsyc.2026.100249_bib35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/15230864251376030","article-title":"Nimodipine blocks histone-induced calcium overload to protect neurons after traumatic brain injury","volume":"43","author":"Cao","year":"2025","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100249_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.STR.0000155686.73908.3e","article-title":"Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial","volume":"36","author":"Pantoni","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41398-019-0514-6","article-title":"Mechanisms and treatment of late-life depression","volume":"9","author":"Alexopoulos","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/gerona\/glab235","article-title":"Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis","volume":"77","author":"Valiengo","year":"2022","journal-title":"J Gerontol Ser A"},{"key":"10.1016\/j.inpsyc.2026.100249_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102710","article-title":"Systematic review of clinical effectiveness of interventions for treatment resistant late-life depression","volume":"107","author":"Pozuelo Moyano","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100249_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.bp.115.164715","article-title":"Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data","volume":"208","author":"Brunoni","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib41","doi-asserted-by":"crossref","first-page":"43850","DOI":"10.1038\/s41598-025-28648-5","article-title":"Efficacy and safety of home-based transcranial direct current stimulation (tDCS) on patients with depressive disorders: a systematic review and meta-analysis of randomized clinical trials","volume":"15","author":"Moshfeghinia","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010308","article-title":"Pathomechanisms of vascular depression in older adults","volume":"23","author":"Jellinger","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jagp.2015.05.010","article-title":"A meta-analysis of executive dysfunction and antidepressant treatment response in late-life depression","volume":"24","author":"Pimontel","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100249_bib44","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/jcm15031198","article-title":"Cognitive impairment, dementia and depression in older adults","volume":"15","author":"Jang","year":"2026","journal-title":"J Clin Med"},{"key":"10.1016\/j.inpsyc.2026.100249_bib45","first-page":"1","article-title":"Definition of treatment-resistant late-life depression: conclusions from a European task force Delphi process","author":"Pozuelo Moyano","year":"2026","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106946","article-title":"Vascular depression: a comprehensive exploration of the definition, mechanisms, and clinical challenges","volume":"211","author":"Wu","year":"2025","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100249_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2215-0366(25)00389-X","article-title":"Beyond a single diagnosis: disentangling midlife depressive symptoms as predictors of dementia","volume":"13","author":"Moyano","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib48","first-page":"22","article-title":"\"The depression-executive dysfunction syndrome of late life\": a specific target for D3 agonists?","volume":"9","author":"Alexopoulos","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib49","article-title":"Pramipexole augmentation for treatment-resistant or anhedonic depression. The real-world evidence: pramipexole augmentation for treatment-resistant or anhedonic depression","author":"Tundo","year":"2026","journal-title":"Ital J Psychiatry"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100249_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2215-0366(25)00194-4","article-title":"Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK","volume":"12","author":"Browning","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100249_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120087","article-title":"Efficacy and tolerability of pramipexole versus antidepressants for Parkinson's disease with depression: a meta-analysis of randomized controlled trials","volume":"392","author":"Wei","year":"2026","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib52","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bph.12988","article-title":"Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors","volume":"172","author":"Wood","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41593-024-01819-9","article-title":"Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors","volume":"28","author":"Enriquez-Traba","year":"2025","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100249_bib54","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2019.10.007","article-title":"Targeting muscarinic acetylcholine receptors for the treatment of psychiatric and neurological disorders","volume":"40","author":"Moran","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100249_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.inpsyc.2026.100249_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100249_bib57","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100249_bib58","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/ncomms5579","article-title":"Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression","volume":"5","author":"Morimoto","year":"2014","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.inpsyc.2026.100249_bib59","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1038\/s41386-018-0121-x","article-title":"Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial","volume":"43","author":"Kaster","year":"2018","journal-title":"Neuropsychopharmacology"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610226000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610226000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:31:45Z","timestamp":1790613105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610226000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1041610226000670"],"URL":"https:\/\/doi.org\/10.1016\/j.inpsyc.2026.100249","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments for vascular depression in older adults: A systematic review","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.inpsyc.2026.100249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Psychogeriatric Association.","name":"copyright","label":"Copyright"}],"article-number":"100249"}}